BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5054212)

  • 1. Clinical implications of monoamine oxidase inhibition.
    Pare CM
    Adv Biochem Psychopharmacol; 1972; 5():441-4. PubMed ID: 5054212
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain amine concentrations after monoamine oxidase inhibitor administration.
    Jones AB; Pare CM; Nicholson WJ; Price K; Stacey RS
    Br Med J; 1972 Jan; 1(5791):17-9. PubMed ID: 5008339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines.
    Glowinski J; Hamon M; Javoy F; Morot-Gaudry Y
    Adv Biochem Psychopharmacol; 1972; 5():423-39. PubMed ID: 4403372
    [No Abstract]   [Full Text] [Related]  

  • 4. [Monoamine oxidase inhibitors and dopamine-(3-hydroxytyramine-) metabolism in the brain].
    Hornykiewicz O; Lisch HJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):30. PubMed ID: 4231842
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of MAO inhibitors on impeding synaptosomal withdrawal and on dopamine metabolism in rat and human brain].
    Tóthfalusi L; Tekes K; Gaál J; Magyar K
    Acta Pharm Hung; 1989; 59 Suppl 1():75-9. PubMed ID: 2641638
    [No Abstract]   [Full Text] [Related]  

  • 6. [Variations of monoamines induced by p-chloro N-methylamphetamine in different parts of the rat brain].
    Boissier JR; Simon P; Guernet M; Tillement JP
    C R Acad Hebd Seances Acad Sci D; 1969 May; 268(18):2298-300. PubMed ID: 4980248
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dopamine metabolism in the rabbit caudate nucleus following partial inhibition of brain monoamine oxidase by nialamide].
    Lisch HJ; Aigner A; Hornykiewicz O
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 261(4):289-98. PubMed ID: 4235430
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
    Colzi A; D'Agostini F; Cesura AM; Borroni E; Da Prada M
    J Pharmacol Exp Ther; 1993 Apr; 265(1):103-11. PubMed ID: 8473998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental findings and new aspects in extrapyramidal diseases].
    Birkmayer W
    Wien Z Nervenheilkd Grenzgeb; 1966; 23(1):128-39. PubMed ID: 4226878
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of monoamine oxidase in determining the amount of monoamines released by drugs in the central nervous system.
    Rutledge CO; Azzaro AJ; Ziance RJ
    Adv Biochem Psychopharmacol; 1972; 5():379-92. PubMed ID: 5054209
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of tranylcypromine upon 5-hydroxytryptaminergic neurons of rat brain stem.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1966; 14(4):365-70. PubMed ID: 5952329
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of L-DOPA on the synthesis and excretion of tyramine.
    Boulton AA; Wu PH
    Adv Neurol; 1974; 5():119-25. PubMed ID: 4613157
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical aspects of depression.
    Coppen AJ
    Int Psychiatry Clin; 1969; 6(2):53-81. PubMed ID: 5817856
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders.
    Hornykiewicz O
    J Psychiatr Res; 1974; 11():249-53. PubMed ID: 4282386
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neurochemical and behavioral study on the mechanism of the antidepressant and anxiolytic effect of co-administration of lithium and monoamine oxidase inhibitors].
    Kitaichi Y
    Hokkaido Igaku Zasshi; 2004 Jan; 79(1):93-101. PubMed ID: 14978979
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoamine fluorescence histochemistry of human post mortem brain.
    Olson L; Nyström B; Seiger A
    Brain Res; 1973 Dec; 63():231-47. PubMed ID: 4764298
    [No Abstract]   [Full Text] [Related]  

  • 18. Conformation study of the inhibition of monoamine uptake in rat brain synaptosomes.
    Tuomisto J; Tuomisto L; Smissman EE
    Ann Med Exp Biol Fenn; 1973; 51(2):51-8. PubMed ID: 4756095
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of progesterone on some brain neurotransmitters in intact rats.
    Chaudhuri SK; Chattopadhyay RN; Maitra SK; Ray S; Chaudhuri S
    Indian J Physiol Pharmacol; 1992 Oct; 36(4):255-8. PubMed ID: 1363321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ; Aarons SF; Frances AJ; Brown RD
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.